| Fund Source | Project Title | Start | End |
| Anderson, Paula | |||
| Inspire Pharmaceuticals (PI) | A multi-center, double-blind, placebo-controlled randomized, efficacy and safety study of Denufosol Tetrasodium (INS37217) inhalation solution in patients with mild cystic fibrosis lung disease (Protocol 08-108) | 1/29/2007 | |
| CFF (PI) | Cystic Fibrosis Database | 7/1/2005 | |
| Hiller, Charles | |||
| Almirall Prodesfarma, (PI) |
A comparative study of LAS 34273 versus placebo in the treatment of stable, moderate to severe COPD, also known as ACCLAIM II |
11/30/2006 | |
| Johnson, Larry | |||
| VA Merit (PI) | Approaches to Gene Therapy for Pulmonary Hypertension | 2008 | 2012 |
| Sakkijha, Hussam | |||
| InterMune (PI) | A randomized, double-blind, placebo-controlled, Phase 3 study of the safety and efficacy of Pirfenidone in patients with idiopathic pulmonary fibrosis (PIPF-006) | 5/30/2006 | 12/31/2009 |
Contact regarding webpage content: GibAnn Berryhill
University of Arkansas for
Medical Sciences
College of Medicine
Department of Internal Medicine,
Slot 832
4301 W. Markham
Little Rock, AR 72205